
|Videos|October 3, 2016
How Can Access to Costly Specialty Drugs be Improved?
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
2
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
3
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
4
Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4
5

















































































































































































































